{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:49:45Z","timestamp":1790653785779,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sj\u00f6gren\u2019s syndrome (SS) is a chronic autoimmune disease characterized by lymphocytic infiltrates in the exocrine glands. Carpal tunnel syndrome (CTS) is suggested to be more frequent among SS patients than in the general population. The aim of this study was to seek associations between the CTS and the laboratory and clinical findings of SS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty patients diagnosed with primary SS (pSS) were examined. Clinical evaluation by a rheumatologist and electrophysiological studies were conducted. Data on laboratory tests results was collected. Control group consisted of 50 sex and age-matched individuals with osteoarthritis (OA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 50 patients in the study group 27 (54%) were diagnosed with CTS. The prevalence of CTS among 50 individuals in the control group was 8%. Among pSS patients with CTS the joint involvement was not more common than in those from the non-CTS group [15 vs. 13 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.945)]. There was an expected difference in sleep disorders [18 vs. 9 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012)] and paresthesia [23 vs. 13 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024)]. The major finding was a significant difference in elevated beta2-microglobulin (B2MG) [23 vs. 13 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024)]. Other studied factors, suggested in the literature as significant in the pSS-related neuropathy, were not statistically different between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study confirms that CTS is more prevalent among pSS patients than in the general population and suggests that a new approach is required towards the pathogenesis of this phenomenon. We hypothesize that CTS is more associated with an overall disease activity than joint involvement as such.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00296-024-05640-2","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T22:01:37Z","timestamp":1720216897000},"page":"1739-1747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Elevated concentration of beta2-microglobulin among patients with carpal tunnel syndrome in the course of primary Sj\u00f6gren syndrome \u2013 a prospective observational study on 50 patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-0671","authenticated-orcid":false,"given":"Iga","family":"Ko\u015bci\u0144ska-Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-4490","authenticated-orcid":false,"given":"Marta","family":"Jask\u00f3lska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-3430","authenticated-orcid":false,"given":"Magdalena","family":"Chyli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-8971","authenticated-orcid":false,"given":"Dawid","family":"Jask\u00f3lski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-2912","authenticated-orcid":false,"given":"Mariusz","family":"Siemi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-8786","authenticated-orcid":false,"given":"Micha\u0142","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"5640_CR1","doi-asserted-by":"publisher","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 9:A305\u2013A310. https:\/\/doi.org\/10.1016\/j.autrev.2009.11.004","journal-title":"Autoimmun Rev"},{"key":"5640_CR2","first-page":"1","volume":"25","author":"A Binard","year":"2007","unstructured":"Binard A, Devauchelle-Pensec V, Fautrel B et al (2007) Epidemiology of Sj\u00f6gren\u2019s syndrome: where are we now? Clin Exp Rheumatol 25:1\u20134","journal-title":"Clin Exp Rheumatol"},{"key":"5640_CR3","doi-asserted-by":"publisher","unstructured":"Casian M, Jurcut C, Dima A et al (2022) Cardiovascular disease in primary Sj\u00f6gren\u2019s syndrome: raising clinicians\u2019 awareness. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.865373","DOI":"10.3389\/fimmu.2022.865373"},{"key":"5640_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sj\u00f6gren\u2019s syndrome. Lancet 366:321\u2013331. https:\/\/doi.org\/10.1016\/S0140-6736(05)66990-5","journal-title":"Lancet"},{"key":"5640_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s100670050105","volume":"18","author":"M Govoni","year":"1999","unstructured":"Govoni M, Bajocchi G, Rizzo N et al (1999) Neurological involvement in primary Sj\u00f6gren\u2019s syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol 18:299\u2013303. https:\/\/doi.org\/10.1007\/s100670050105","journal-title":"Clin Rheumatol"},{"key":"5640_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1600-0404.1990.tb00951.x","volume":"81","author":"A Hietaharju","year":"2009","unstructured":"Hietaharju A, Yli-Kerttula U, H\u00e4kkinen V, Frey H (2009) Nervous system manifestations in Sj\u00f6gren\u2019s syndrome. Acta Neurol Scand 81:144\u2013152. https:\/\/doi.org\/10.1111\/j.1600-0404.1990.tb00951.x","journal-title":"Acta Neurol Scand"},{"key":"5640_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s004150170135","volume":"248","author":"C Lafitte","year":"2001","unstructured":"Lafitte C, Amoura Z, Cacoub P et al (2001) Neurological complications of primary Sj\u00f6gren\u2019s syndrome. J Neurol 248:577\u2013584. https:\/\/doi.org\/10.1007\/s004150170135","journal-title":"J Neurol"},{"key":"5640_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1055\/s-0043-1777105","volume":"81","author":"OGP Barsottini","year":"2023","unstructured":"Barsottini OGP, de Moraes MPM, Fraiman PHA et al (2023) Sj\u00f6gren\u2019s syndrome: a neurological perspective. Arq Neuropsiquiatr 81:1077\u20131083. https:\/\/doi.org\/10.1055\/s-0043-1777105","journal-title":"Arq Neuropsiquiatr"},{"key":"5640_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","volume":"82","author":"PP Pavlakis","year":"2011","unstructured":"Pavlakis PP, Alexopoulos H, Kosmidis ML et al (2011) Peripheral neuropathies in Sj\u00f6gren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 82:798\u2013802. https:\/\/doi.org\/10.1136\/jnnp.2010.222109","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5640_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5114\/reum.2018.75521","volume":"56","author":"J Perzy\u0144ska-Mazan","year":"2018","unstructured":"Perzy\u0144ska-Mazan J, Ma\u015bli\u0144ska M, Gasik R (2018) Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome. Rheumatology 56:99\u2013105. https:\/\/doi.org\/10.5114\/reum.2018.75521","journal-title":"Rheumatology"},{"key":"5640_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MD.0b013e31820fd2d1","volume":"90","author":"D S\u00e8ne","year":"2011","unstructured":"S\u00e8ne D, Jallouli M, Lefaucheur J-P et al (2011) Peripheral neuropathies associated with primary Sj\u00f6gren syndrome. Medicine 90:133\u2013138. https:\/\/doi.org\/10.1097\/MD.0b013e31820fd2d1","journal-title":"Medicine"},{"key":"5640_CR12","first-page":"1552","volume":"30","author":"J Font","year":"2003","unstructured":"Font J, Ramos-Casals M, de la Red G et al (2003) Pure sensory neuropathy in primary Sj\u00f6gren\u2019s syndrome. Longterm prospective follow-up and review of the literature. J Rheumatol 30:1552\u20131557","journal-title":"J Rheumatol"},{"key":"5640_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/acn3.51053","volume":"7","author":"J Tani","year":"2020","unstructured":"Tani J, Liao H, Hsu H et al (2020) Immune-mediated axonal dysfunction in seropositive and seronegative primary Sj\u00f6gren\u2019s syndrome. Ann Clin Transl Neurol 7:819\u2013828. https:\/\/doi.org\/10.1002\/acn3.51053","journal-title":"Ann Clin Transl Neurol"},{"key":"5640_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/ene.15555","volume":"30","author":"A Liampas","year":"2023","unstructured":"Liampas A, Parperis K, Erotocritou MF et al (2023) Primary Sj\u00f6gren syndrome-related peripheral neuropathy: a systematic review and meta\u2010analysis. Eur J Neurol 30:255\u2013265. https:\/\/doi.org\/10.1111\/ene.15555","journal-title":"Eur J Neurol"},{"key":"5640_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40001-023-01013-w","volume":"28","author":"Z Wu","year":"2023","unstructured":"Wu Z, Wang D, Chen L et al (2023) Analysis of clinical features and risk factors of peripheral neuropathy in patients with primary Sj\u00f6gren\u2019s syndrome. Eur J Med Res 28:54. https:\/\/doi.org\/10.1186\/s40001-023-01013-w","journal-title":"Eur J Med Res"},{"key":"5640_CR16","doi-asserted-by":"publisher","unstructured":"Jask\u00f3lska M, Chyli\u0144ska M, Masiak A et al (2020) Neuro-Sj\u00f6gren: uncommon or underestimated problem? https:\/\/doi.org\/10.1002\/brb3.1665. Brain Behav 10:","DOI":"10.1002\/brb3.1665"},{"key":"5640_CR17","doi-asserted-by":"publisher","first-page":"116744","DOI":"10.1016\/j.lfs.2019.116744","volume":"233","author":"R Illescas-Montes","year":"2019","unstructured":"Illescas-Montes R, Melguizo-Rodr\u00edguez L, Ruiz C, Costela-Ruiz VJ (2019) Vitamin D and autoimmune diseases. Life Sci 233:116744. https:\/\/doi.org\/10.1016\/j.lfs.2019.116744","journal-title":"Life Sci"},{"key":"5640_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5152\/eurjrheum.2020.19132","volume":"7","author":"P Jord\u00e1n-Gonz\u00e1lez","year":"2020","unstructured":"Jord\u00e1n-Gonz\u00e1lez P, Gago-Pi\u00f1ero R, Varela-Rosario N et al (2020) Characterization of a subset of patients with primary Sj\u00f6gren\u2019s syndrome initially presenting with C3 or C4 hypocomplementemia. Eur J Rheumatol 7:112\u2013117. https:\/\/doi.org\/10.5152\/eurjrheum.2020.19132","journal-title":"Eur J Rheumatol"},{"key":"5640_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00672","author":"JM Thurman","year":"2019","unstructured":"Thurman JM, Yapa R (2019) Complement therapeutics in autoimmune disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00672. 10:","journal-title":"Front Immunol"},{"key":"5640_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12882-017-0658-7","volume":"18","author":"M Pan","year":"2017","unstructured":"Pan M, Zhang J, Li Z et al (2017) Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study. BMC Nephrol 18:231. https:\/\/doi.org\/10.1186\/s12882-017-0658-7","journal-title":"BMC Nephrol"},{"key":"5640_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jbspin.2007.09.014","volume":"75","author":"Y El Miedany","year":"2008","unstructured":"El Miedany Y, Ashour S, Youssef S et al (2008) Clinical diagnosis of carpal tunnel syndrome: old tests\u2013new concepts. Joint Bone Spine 75:451\u2013457. https:\/\/doi.org\/10.1016\/j.jbspin.2007.09.014","journal-title":"Joint Bone Spine"},{"key":"5640_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/01.bto.0000220073.29489.6c","volume":"21","author":"P Feldon","year":"2006","unstructured":"Feldon P, Terrono AL (2006) Carpal tunnel syndrome in rheumatoid arthritis. Techniques Orthop 21:42\u201347. https:\/\/doi.org\/10.1097\/01.bto.0000220073.29489.6c","journal-title":"Techniques Orthop"},{"key":"5640_CR23","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Seror R et al (2015) Characterization of systemic disease in primary Sj\u00f6gren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 54:2230\u20132238. https:\/\/doi.org\/10.1093\/rheumatology\/kev200","journal-title":"Rheumatology"},{"key":"5640_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/ard.62.1.94","volume":"62","author":"C Vitali","year":"2003","unstructured":"Vitali C (2003) Classification criteria for Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 62:94\u201395. https:\/\/doi.org\/10.1136\/ard.62.1.94","journal-title":"Ann Rheum Dis"},{"key":"5640_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance Cohort. Arthritis Care Res (Hoboken) 64:475\u2013487. https:\/\/doi.org\/10.1002\/acr.21591","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5640_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mus.25204","volume":"54","author":"T Dillingham","year":"2016","unstructured":"Dillingham T, Chen S, Andary M et al (2016) Establishing high-quality reference values for nerve conduction studies: a report from the normative data task force of the American Association of Neuromuscular & Electrodiagnostic Medicine. Muscle Nerve 54:366\u2013370. https:\/\/doi.org\/10.1002\/mus.25204","journal-title":"Muscle Nerve"},{"key":"5640_CR27","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.clinph.2005.04.003","volume":"116","author":"H Tankisi","year":"2005","unstructured":"Tankisi H, Pugdahl K, Fuglsang-Frederiksen A et al (2005) Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 116:1571\u20131580. https:\/\/doi.org\/10.1016\/j.clinph.2005.04.003","journal-title":"Clin Neurophysiol"},{"key":"5640_CR28","doi-asserted-by":"publisher","unstructured":"Graham B, Regehr G, Naglie G, Wright JG (2006) Development and validation of diagnostic criteria for carpal tunnel syndrome. J Hand Surg Am 31. https:\/\/doi.org\/10.1016\/j.jhsa.2006.03.005. :919.e1-919.e7","DOI":"10.1016\/j.jhsa.2006.03.005"},{"key":"5640_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mus.22208","volume":"44","author":"RA Werner","year":"2011","unstructured":"Werner RA, Andary M (2011) Electrodiagnostic evaluation of carpal tunnel syndrome. Muscle Nerve 44:597\u2013607. https:\/\/doi.org\/10.1002\/mus.22208","journal-title":"Muscle Nerve"},{"key":"5640_CR30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/mus.10185","volume":"25","author":"American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medicine and Rehabilitation","year":"2002","unstructured":"American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medicine and Rehabilitation (2002) Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: Summary statement. Muscle Nerve 25:918\u2013922. https:\/\/doi.org\/10.1002\/mus.10185","journal-title":"Muscle Nerve"},{"key":"5640_CR31","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","volume":"1","author":"R Seror","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P et al (2015) EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide. RMD Open 1:e000022\u2013e000022. https:\/\/doi.org\/10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"key":"5640_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X et al (2011) EULAR Sj\u00f6gren\u2019s syndrome patient reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 70:968\u2013972. https:\/\/doi.org\/10.1136\/ard.2010.143743","journal-title":"Ann Rheum Dis"},{"key":"5640_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-387-5","volume-title":"Handbook of clinical rating scales and Assessment in Psychiatry and Mental Health","author":"L Baer","year":"2010","unstructured":"Baer L, Blais MA (2010) Handbook of clinical rating scales and Assessment in Psychiatry and Mental Health. Humana, Totowa, NJ"},{"key":"5640_CR34","first-page":"S40","volume":"34","author":"PLCM van Riel","year":"2016","unstructured":"van Riel PLCM, Renskers L (2016) The Disease activity score (DAS) and the Disease Activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol 34:S40\u2013S44","journal-title":"Clin Exp Rheumatol"},{"key":"5640_CR35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4081\/cp.2019.1190","volume":"9","author":"DS Meena","year":"2019","unstructured":"Meena DS, Bohra GK (2019) Primary sjogren\u2019s syndrome presenting as autoimmune cytopenia. Clin Pract 9:1190. https:\/\/doi.org\/10.4081\/cp.2019.1190","journal-title":"Clin Pract"},{"key":"5640_CR36","doi-asserted-by":"publisher","unstructured":"Vrancken AFJE, G Said (2013) Vasculitic neuropathy. 463\u2013483. https:\/\/doi.org\/10.1016\/B978-0-444-52902-2.00026-6","DOI":"10.1016\/B978-0-444-52902-2.00026-6"},{"key":"5640_CR37","first-page":"102","volume":"36","author":"L Sampaio","year":"2011","unstructured":"Sampaio L, Silva LG, Terroso G et al (2011) Vasculitic neuropathy. Acta Reumatol Port 36:102\u2013109","journal-title":"Acta Reumatol Port"},{"key":"5640_CR38","first-page":"1615","volume":"65","author":"IA Mansi","year":"2002","unstructured":"Mansi IA, Opran A, Rosner F (2002) ANCA-associated small-vessel vasculitis. Am Fam Physician 65:1615\u20131620","journal-title":"Am Fam Physician"},{"key":"5640_CR39","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/01.ASN.0000016442.33680.3E","volume":"13","author":"L Kamesh","year":"2002","unstructured":"Kamesh L, Harper L, Savage COS (2002) ANCA-positive vasculitis. J Am Soc Nephrol 13:1953\u20131960. https:\/\/doi.org\/10.1097\/01.ASN.0000016442.33680.3E","journal-title":"J Am Soc Nephrol"},{"key":"5640_CR40","doi-asserted-by":"publisher","unstructured":"Duarte AC, Ribeiro R, Macedo AM, Santos MJ (2023) ANCA-associated vasculitis: overview and practical issues of diagnosis and therapy from a European perspective. Porto Biomed J 8. https:\/\/doi.org\/10.1097\/j.pbj.0000000000000237","DOI":"10.1097\/j.pbj.0000000000000237"},{"key":"5640_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5525156","volume":"2021","author":"MM Brzozowska","year":"2021","unstructured":"Brzozowska MM, Banthia S, Thompson S et al (2021) Severe hypothyroidism complicated by myopathy and neuropathy with atypical demyelinating features. Case Rep Endocrinol 2021:1\u20136. https:\/\/doi.org\/10.1155\/2021\/5525156","journal-title":"Case Rep Endocrinol"},{"key":"5640_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jnnp.68.6.750","volume":"68","author":"RF Duyff","year":"2000","unstructured":"Duyff RF (2000) Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 68:750\u2013755. https:\/\/doi.org\/10.1136\/jnnp.68.6.750","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5640_CR43","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/16464.7316","author":"SS Karne","year":"2016","unstructured":"Karne SS (2016) Carpal tunnel syndrome in hypothyroidism. J Clin Diagn Res. https:\/\/doi.org\/10.7860\/JCDR\/2016\/16464.7316","journal-title":"J Clin Diagn Res"},{"key":"5640_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4274\/gulhane.galenos.2020.1070","volume":"62","author":"D Tecer","year":"2020","unstructured":"Tecer D, B\u00fcy\u00fck\u015fireci D, G\u00fcnendi Z, G\u00f6\u011f\u00fc\u015f F (2020) The association of serum beta-2-microglobulin with autoantibody production and disease activity in patients with primary Sj\u00f6gren\u2019s syndrome. G\u00fclhane Med J 62:272\u2013277. https:\/\/doi.org\/10.4274\/gulhane.galenos.2020.1070","journal-title":"G\u00fclhane Med J"},{"key":"5640_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/pm.2021.104207","volume":"20","author":"M Dominiak","year":"2021","unstructured":"Dominiak M, Antosik-W\u00f3jci\u0144ska AZ, Baron M, Mierzejewski P (2021) Screening and treatment of depression \u2013 recommendations for Polish health professionals. Menopause Rev 20:1\u201313. https:\/\/doi.org\/10.5114\/pm.2021.104207","journal-title":"Menopause Rev"},{"key":"5640_CR46","doi-asserted-by":"publisher","unstructured":"Argyropoulos CP, Chen SS, Ng Y-H et al (2017) Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med (Lausanne) 4. https:\/\/doi.org\/10.3389\/fmed.2017.00073","DOI":"10.3389\/fmed.2017.00073"},{"key":"5640_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/346751a0","volume":"346","author":"B P\u00e9rarnau","year":"1990","unstructured":"P\u00e9rarnau B, Siegrist C-A, Gillet A et al (1990) \u03b22-Microglobulin restriction of antigen presentation. Nature 346:751\u2013754. https:\/\/doi.org\/10.1038\/346751a0","journal-title":"Nature"},{"key":"5640_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/1521-4141(200102)31:2<440::AID-IMMU440>3.0.CO;2-0","volume":"31","author":"S Tafuro","year":"2001","unstructured":"Tafuro S, Meier U-C, Dunbar PR et al (2001) Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-\u03b22m fusion molecules. Eur J Immunol 31:440\u2013449. https:\/\/doi.org\/10.1002\/1521-4141(200102)31:2%3C440::AID-IMMU440%3E3.0.CO;2-0","journal-title":"Eur J Immunol"},{"key":"5640_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5644\/ama2006-124.255","volume":"48","author":"M Kuhari\u0107","year":"2019","unstructured":"Kuhari\u0107 M, Zibar L (2019) Screening for carpal tunnel syndrome in patients on chronic hemodialysis. Acta Med Acad 48:167. https:\/\/doi.org\/10.5644\/ama2006-124.255","journal-title":"Acta Med Acad"},{"key":"5640_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0006-291X(85)91948-5","volume":"129","author":"F Gejyo","year":"1985","unstructured":"Gejyo F, Yamada T, Odani S et al (1985) A new form of amyloid protein associated with chronic hemodialysis was identified as \u03b22-microglobulin. Biochem Biophys Res Commun 129:701\u2013706. https:\/\/doi.org\/10.1016\/0006-291X(85)91948-5","journal-title":"Biochem Biophys Res Commun"},{"key":"5640_CR51","doi-asserted-by":"publisher","unstructured":"Sedighi O, Abediankenari S, Omranifar B (2014) Association between plasma beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease. Nephrourol Mon 7. https:\/\/doi.org\/10.5812\/numonthly.23563","DOI":"10.5812\/numonthly.23563"},{"key":"5640_CR52","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/prca.200900171","volume":"4","author":"E H\u00f8gdall","year":"2010","unstructured":"H\u00f8gdall E, Fung ET, Christensen IJ et al (2010) Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients. Proteom Clin Appl 4:940\u2013952. https:\/\/doi.org\/10.1002\/prca.200900171","journal-title":"Proteom Clin Appl"},{"key":"5640_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.arcmed.2013.03.008","volume":"44","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang L, Ji P et al (2013) Correlation of serum \u03b22-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer. Arch Med Res 44:259\u2013265. https:\/\/doi.org\/10.1016\/j.arcmed.2013.03.008","journal-title":"Arch Med Res"},{"key":"5640_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1744-313X.1996.tb00132.x","volume":"23","author":"T Klein","year":"1996","unstructured":"Klein T, Levin I, Niska A et al (1996) Correlation between tumour and serum \u03b2 2 m expression in patients with breast cancer. Int J Immunogenet 23:417\u2013423. https:\/\/doi.org\/10.1111\/j.1744-313X.1996.tb00132.x","journal-title":"Int J Immunogenet"},{"key":"5640_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10735-014-9597-9","volume":"46","author":"J Sun","year":"2015","unstructured":"Sun J, Yang Z, Miao X et al (2015) ATP5b and \u03b22-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. J Mol Histol 46:57\u201365. https:\/\/doi.org\/10.1007\/s10735-014-9597-9","journal-title":"J Mol Histol"},{"key":"5640_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/689795","volume":"2014","author":"G Lucarelli","year":"2014","unstructured":"Lucarelli G, Ditonno P, Bettocchi C et al (2014) Diagnostic and prognostic role of preoperative circulating CA 15\u2009\u2013\u20093, CA 125, and beta-2 microglobulin in renal cell carcinoma. Dis Markers 2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/689795","journal-title":"Dis Markers"},{"key":"5640_CR57","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10067-013-2220-8","volume":"32","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Inokuma S, Matsubara E et al (2013) Serum \u03b22-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset still\u2019s disease. Clin Rheumatol 32:999\u20131005. https:\/\/doi.org\/10.1007\/s10067-013-2220-8","journal-title":"Clin Rheumatol"},{"key":"5640_CR58","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/0961203312447668","volume":"21","author":"M-L Hermansen","year":"2012","unstructured":"Hermansen M-L, Hummelsh\u00f8j L, Lundsgaard D et al (2012) Increased serum \u03b22-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus 21:1098\u20131104. https:\/\/doi.org\/10.1177\/0961203312447668","journal-title":"Lupus"},{"key":"5640_CR59","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.2214\/AJR.04.1309","volume":"185","author":"E Kiss","year":"2005","unstructured":"Kiss E, Keusch G, Zanetti M et al (2005) Dialysis-related amyloidosis revisited. Am J Roentgenol 185:1460\u20131467. https:\/\/doi.org\/10.2214\/AJR.04.1309","journal-title":"Am J Roentgenol"},{"key":"5640_CR60","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/IJNRD.S84784","volume":"9","author":"R Scarpioni","year":"2016","unstructured":"Scarpioni R, Ricardi M, Albertazzi V et al (2016) Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis Volume 9:319\u2013328. https:\/\/doi.org\/10.2147\/IJNRD.S84784","journal-title":"Int J Nephrol Renovasc Dis Volume"},{"key":"5640_CR61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/pgmj.51.597.450","volume":"51","author":"DJ Warren","year":"1975","unstructured":"Warren DJ, Otieno LS (1975) Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 51:450\u2013452. https:\/\/doi.org\/10.1136\/pgmj.51.597.450","journal-title":"Postgrad Med J"},{"key":"5640_CR62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0272-6386(86)80133-0","volume":"7","author":"AZ Fenves","year":"1986","unstructured":"Fenves AZ, Emmett M, White MG et al (1986) Carpal tunnel syndrome with cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients. Am J Kidney Dis 7:130\u2013134. https:\/\/doi.org\/10.1016\/S0272-6386(86)80133-0","journal-title":"Am J Kidney Dis"},{"key":"5640_CR63","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/ajcp\/88.3.302","volume":"88","author":"A Fuchs","year":"1987","unstructured":"Fuchs A, Jagirdar J, Schwartz IS (1987) Beta 2-microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis: a New type of amyloid. Am J Clin Pathol 88:302\u2013307. https:\/\/doi.org\/10.1093\/ajcp\/88.3.302","journal-title":"Am J Clin Pathol"},{"key":"5640_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10157-021-02122-8","volume":"26","author":"M Hatano","year":"2022","unstructured":"Hatano M, Kitajima I, Yamamoto S et al (2022) Dialysis-related carpal tunnel syndrome in the past 40 years. Clin Exp Nephrol 26:68\u201374. https:\/\/doi.org\/10.1007\/s10157-021-02122-8","journal-title":"Clin Exp Nephrol"},{"key":"5640_CR65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ki.1986.196","volume":"30","author":"F Gejyo","year":"1986","unstructured":"Gejyo F, Odani S, Yamada T et al (1986) \u03b22-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 30:385\u2013390. https:\/\/doi.org\/10.1038\/ki.1986.196","journal-title":"Kidney Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05640-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:03:41Z","timestamp":1724450621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["5640"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05640-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has any conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}